Multimodal imaging and advanced quantitative techniques for HER-2 status prediction in breast cancer
{{output}}
HER-2-positive breast cancer is a biologically distinct subtype, accurate early assessment of HER-2 status is therefore critical for guiding personalized treatment. Currently mainly detected through immunohistochemistry (IHC) and fluorescence in situ hybridiza... ...
